Matsue, Kosei http://orcid.org/0000-0002-8669-9865
Kumagai, Kyoya
Sugiura, Isamu
Ishikawa, Takayuki
Igarashi, Tadahiko
Sato, Tsutomu
Uchiyama, Michihiro
Miyamoto, Toshihiro
Ono, Takaaki
Ueda, Yasunori
Kiguchi, Toru
Sunaga, Yoshinori
Sasaki, Toru
Suzuki, Kenshi
Funding for this research was provided by:
Sanofi K.K.
Article History
Received: 20 December 2017
Revised: 11 July 2018
Accepted: 11 July 2018
First Online: 24 July 2018
Change Date: 30 August 2018
Change Type: Correction
Change Details: The affiliation of the last author, Kenshi Suzuki has been incorrectly published in the original publication of the article. The correct affiliation is provided in this correction.
Compliance with ethical standards
:
: T. Ono has received research funding from Celgene K.K., Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd. and MSD K.K. Y. Ueda has consulting fees from Kainos Laboratories, Inc. and Ablynx NV, and has received research funding from Eli Lilly Japan K.K., Sumitomo Dainippon Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Celgene K.K., Symbio Pharmaceuticals Limited, Astellas Pharma Inc. and Eisai Co., Ltd. Y. Sunaga and T. Sasaki are employees of Sanofi K.K. The other authors have no conflicts of interest to declare.